PBE (PBE) Stock Price & Analysis
PBE (PBE) fell 2.51% to USD 95.19 as of September 8, 2026 at 15:30 UTC, according to Nexqual real-time market data.
PBE last closed at USD 95.19; the session ranged USD 95.19–95.48 on volume of 1,167 shares. Market capitalization is —, with a 52-week range of USD 67.69–98.82 (PCX). Source: Nexqual, September 8, 2026 at 15:30 UTC.
Key Statistics (as of September 8, 2026 at 15:30 UTC)
| Price | USD 95.19 |
|---|---|
| Change | ▼ 2.51% (down) |
| Previous Close | USD 95.19 |
| Open | USD 95.19 |
| Day Range | USD 95.19 – 95.48 |
| 52-Week Range | USD 67.69 – 98.82 |
| Volume | 1,167 shares |
| Market Cap | — |
| Exchange | PCX |
Technical Analysis (PBE)
Nexqual's technical model rates PBE "BUY" based on 4 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 15:30 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 49.92 (neutral) |
| vs SMA50 | Above (USD 93.18) |
| MACD | 1.39 (positive) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PJP | Invesco Pharmaceuticals ETF | USD 126.44 | ▼ 2.43% |
| FBT | First Trust Amex Biotech Index | USD 266.18 | ▼ 2.78% |
| PBJ | Invesco Food & Beverage ETF | USD 47.69 | ▼ 0.9% |
| PKB | Invesco Building & Construction | USD 97.17 | ▲ 0.95% |
| BBH | VanEck Biotech ETF | USD 233.76 | ▼ 4.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 15:30 UTC. This page is informational and not investment advice.